AVXL
Price
$9.49
Change
+$0.18 (+1.93%)
Updated
Apr 24, 02:17 PM (EDT)
Capitalization
790.25M
14 days until earnings call
SLGL
Price
$0.78
Change
+$0.08 (+11.43%)
Updated
Apr 24, 02:42 PM (EDT)
Capitalization
19.64M
15 days until earnings call
Ad is loading...

AVXL vs SLGL

Header iconAVXL vs SLGL Comparison
Open Charts AVXL vs SLGLBanner chart's image
Anavex Life Sciences
Price$9.49
Change+$0.18 (+1.93%)
Volume$639
Capitalization790.25M
Sol-Gel Technologies
Price$0.78
Change+$0.08 (+11.43%)
Volume$500
Capitalization19.64M
AVXL vs SLGL Comparison Chart
Loading...
AVXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVXL vs. SLGL commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVXL is a StrongBuy and SLGL is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (AVXL: $9.29 vs. SLGL: $0.71)
Brand notoriety: AVXL and SLGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVXL: 89% vs. SLGL: 90%
Market capitalization -- AVXL: $790.25M vs. SLGL: $19.64M
AVXL [@Biotechnology] is valued at $790.25M. SLGL’s [@Biotechnology] market capitalization is $19.64M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVXL’s FA Score shows that 0 FA rating(s) are green whileSLGL’s FA Score has 0 green FA rating(s).

  • AVXL’s FA Score: 0 green, 5 red.
  • SLGL’s FA Score: 0 green, 5 red.
According to our system of comparison, AVXL is a better buy in the long-term than SLGL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVXL’s TA Score shows that 7 TA indicator(s) are bullish while SLGL’s TA Score has 5 bullish TA indicator(s).

  • AVXL’s TA Score: 7 bullish, 3 bearish.
  • SLGL’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, AVXL is a better buy in the short-term than SLGL.

Price Growth

AVXL (@Biotechnology) experienced а +5.09% price change this week, while SLGL (@Biotechnology) price change was +46.90% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.07%. For the same industry, the average monthly price growth was -6.06%, and the average quarterly price growth was -12.59%.

Reported Earning Dates

AVXL is expected to report earnings on Aug 12, 2025.

SLGL is expected to report earnings on Aug 14, 2025.

Industries' Descriptions

@Biotechnology (+7.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVXL($790M) has a higher market cap than SLGL($19.6M). AVXL YTD gains are higher at: -13.501 vs. SLGL (-24.191). SLGL has higher annual earnings (EBITDA): -11.32M vs. AVXL (-45.2M). AVXL has more cash in the bank: 121M vs. SLGL (28.1M). AVXL has less debt than SLGL: AVXL (88.2K) vs SLGL (1.31M). SLGL has higher revenues than AVXL: SLGL (11.7M) vs AVXL (0).
AVXLSLGLAVXL / SLGL
Capitalization790M19.6M4,031%
EBITDA-45.2M-11.32M399%
Gain YTD-13.501-24.19156%
P/E RatioN/AN/A-
Revenue011.7M-
Total Cash121M28.1M431%
Total Debt88.2K1.31M7%
FUNDAMENTALS RATINGS
AVXL vs SLGL: Fundamental Ratings
AVXL
SLGL
OUTLOOK RATING
1..100
5837
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
56
Fair valued
PROFIT vs RISK RATING
1..100
74100
SMR RATING
1..100
9392
PRICE GROWTH RATING
1..100
3760
P/E GROWTH RATING
1..100
10097
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SLGL's Valuation (56) in the Pharmaceuticals Major industry is in the same range as AVXL (61) in the Biotechnology industry. This means that SLGL’s stock grew similarly to AVXL’s over the last 12 months.

AVXL's Profit vs Risk Rating (74) in the Biotechnology industry is in the same range as SLGL (100) in the Pharmaceuticals Major industry. This means that AVXL’s stock grew similarly to SLGL’s over the last 12 months.

SLGL's SMR Rating (92) in the Pharmaceuticals Major industry is in the same range as AVXL (93) in the Biotechnology industry. This means that SLGL’s stock grew similarly to AVXL’s over the last 12 months.

AVXL's Price Growth Rating (37) in the Biotechnology industry is in the same range as SLGL (60) in the Pharmaceuticals Major industry. This means that AVXL’s stock grew similarly to SLGL’s over the last 12 months.

SLGL's P/E Growth Rating (97) in the Pharmaceuticals Major industry is in the same range as AVXL (100) in the Biotechnology industry. This means that SLGL’s stock grew similarly to AVXL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVXLSLGL
RSI
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
71%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
74%
Declines
ODDS (%)
Bearish Trend 21 days ago
80%
Bearish Trend 23 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
AVXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SPRAX22.03N/A
N/A
PGIM Quant Solutions Mid-Cap Val A
FSLEX34.34N/A
N/A
Fidelity Environment & Alternative Engy
MXCAX10.42N/A
N/A
BlackRock Emerging Markets Ex-Chn Inv A
TILPX24.08N/A
N/A
Nuveen Large Cap Growth Premier
QAMNX20.43N/A
N/A
Federated Hermes MDT Market Neutral A

AVXL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVXL has been loosely correlated with PLRX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if AVXL jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVXL
1D Price
Change %
AVXL100%
+0.87%
PLRX - AVXL
48%
Loosely correlated
+2.33%
TENX - AVXL
47%
Loosely correlated
+7.06%
AXON - AVXL
45%
Loosely correlated
+3.82%
RXRX - AVXL
45%
Loosely correlated
-0.89%
NTLA - AVXL
42%
Loosely correlated
-2.65%
More

SLGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLGL has been loosely correlated with TRAW. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if SLGL jumps, then TRAW could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLGL
1D Price
Change %
SLGL100%
+18.11%
TRAW - SLGL
53%
Loosely correlated
-11.59%
RAPT - SLGL
45%
Loosely correlated
+5.93%
AVXL - SLGL
30%
Poorly correlated
+0.87%
RPRX - SLGL
29%
Poorly correlated
-1.62%
EYPT - SLGL
28%
Poorly correlated
+3.15%
More